<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02621554</url>
  </required_header>
  <id_info>
    <org_study_id>resveratrol_mpi_01</org_study_id>
    <nct_id>NCT02621554</nct_id>
  </id_info>
  <brief_title>Impact of Resveratrol on Brain Function and Structure</brief_title>
  <official_title>Impact of Resveratrol on Brain Function and Structure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Max Planck Institute for Human Cognitive and Brain Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Leipzig</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Evolva SA</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Max Planck Institute for Human Cognitive and Brain Sciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will investigate whether resveratrol could provide positive effects on memory and
      brain structures and functions in healthy elderly participants.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cell and animal studies postulated various beneficial effects of resveratrol, ranging from a
      reduction of inflammatory processes and the treatment of cancer to the prevention of
      cardiovascular diseases and stroke. With regard to cognitive decline, rodent models for
      Alzheimer's disease (AD) showed improved learning and decelerated hippocampal
      neurodegeneration after intake of resveratrol.

      Animal and first human studies provided evidence that resveratrol might serve as an easy,
      cost-effective option to develop novel prevention and treatment strategies against
      age-associated cognitive decline. To test this hypothesis, the researchers study general
      brain structure and function on healthy older individuals (&gt; 60years old).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Actual">January 2017</completion_date>
  <primary_completion_date type="Actual">January 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline Verbal Learning Task Scores at 6 months</measure>
    <time_frame>Baseline (timepoint 0), after 6 months (timepoint 6 months)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline Verbal Learning Task Scores at 12 months</measure>
    <time_frame>after 12 months (timepoint 12 months)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mini Mental State Examination</measure>
    <time_frame>Baseline (timepoint 0), after 6 months (timepoint 6 months) and after 12 months (timepoint 12 months)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Structural changes on the brain MRI images</measure>
    <time_frame>Baseline (timepoint 0), after 6 months (timepoint 6 months) and after 12 months (timepoint 12 months)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional changes on the brain MRI images</measure>
    <time_frame>Baseline (timepoint 0), after 6 months (timepoint 6 months) and after 12 months (timepoint 12 months)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma biomarkers</measure>
    <time_frame>Baseline (timepoint 0), after 6 months (timepoint 6 months) and after 12 months (timepoint 12 months)</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>resveratrol supplementation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dietary Supplement: Resveratrol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo supplementation</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Dietary Supplement: Placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>resveratrol supplementation</intervention_name>
    <description>6 months of resveratrol supplementation</description>
    <arm_group_label>resveratrol supplementation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>6 months of placebo intake</description>
    <arm_group_label>placebo supplementation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  subjects who are healthy or with subjective memory complaints

          -  older than 60 years old

          -  normal to overweight participants (BMI: 22-40 kg/sqm)

        Exclusion Criteria:

          -  dementia

          -  Psychiatric diseases

          -  severe untreated internal diseases

          -  diabetes

          -  younger than 60 years

          -  BMI &lt; 22 or &gt;40
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Arno Villringer, Prof.</last_name>
    <role>Study Chair</role>
    <affiliation>Max Planck Institute for Human Cognitive and Brain Sciences</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Arno Villringer</last_name>
    <role>Study Director</role>
    <affiliation>Max Planck Institute for Human Cognitive and Brain Sciences</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Veronica Witte</last_name>
    <role>Study Director</role>
    <affiliation>Max Planck Institute for Human Cognitive and Brain Sciences</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Veronica Witte</last_name>
    <role>Principal Investigator</role>
    <affiliation>Max Planck Institute for Human Cognitive and Brain Sciences</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Neurology, Max Planck Institute for Human Cognitive and Brain Sciences</name>
      <address>
        <city>Leipzig</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 6, 2015</study_first_submitted>
  <study_first_submitted_qc>December 1, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 3, 2015</study_first_posted>
  <last_update_submitted>February 6, 2017</last_update_submitted>
  <last_update_submitted_qc>February 6, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 8, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Memory</keyword>
  <keyword>Resveratrol</keyword>
  <keyword>elderly</keyword>
  <keyword>cognition</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Resveratrol</mesh_term>
  </intervention_browse>
  <study_docs>
    <study_doc>
      <doc_type>Statistical Analysis Plan</doc_type>
      <doc_url>https://drive.google.com/open?id=0Bx6LS4H2DroFNnVaQWlTakh5dEU</doc_url>
    </study_doc>
    <study_doc>
      <doc_type>Statistical Analysis Plan</doc_type>
      <doc_url>https://drive.google.com/open?id=0Bx6LS4H2DroFazRhT1hZVm41RzA</doc_url>
      <doc_comment>05.01.2017 updated because of an amendment of ethnic proposal.</doc_comment>
    </study_doc>
  </study_docs>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

